In 2020 the revision of ICHE9 has became effective in the ICH regions.
\nBeyond the immediate operational consequences in terms of study documentation development, it has become clearer and clearer that the introduction of the Estimand framework may require methodological solutions which were not common practice in drug development when the revised guidance was released.<\/p>\n
In this context, causal inference, or the problem of causality in general, has received a lot of attention in recent years. It appears to provide a suitable methodological framework for tackling some of these challenges.<\/p>\n
Five years from now the event touched on Estimands. In this year’s edition, the ESF goes back to Estimands to better understand the implications of the introduction of the ICHE9 (R1) guidance in terms of how the traditional approach of statistical inference may be affected in its fundamentals of sample size, testing, and estimation by the arrival of causal inference.<\/p>\n
The conference will focus, among others, on the following areas:<\/p>\n
Scientific Board Who should attend? In 2020 the revision of ICHE9 has became effective in the ICH regions. Beyond the immediate operational consequences in terms of study documentation development, it has become clearer and clearer that the introduction of the Estimand framework may require methodological solutions which were not common practice in drug development when the revised guidance was released. … Continued<\/a><\/p>\n","protected":false},"featured_media":477,"template":"","meta":[],"product_brand":[],"product_cat":[47],"product_tag":[],"class_list":["post-2407","product","type-product","status-publish","has-post-thumbnail","conference_topics-statistica-e-data-management","productgroup-european-statistical-forum","product_cat-conferenze","first","instock","taxable","shipping-taxable","purchasable","product-type-variable"],"_links":{"self":[{"href":"https:\/\/lsacademy.com\/it\/wp-json\/wp\/v2\/product\/2407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lsacademy.com\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/lsacademy.com\/it\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lsacademy.com\/it\/wp-json\/wp\/v2\/media\/477"}],"wp:attachment":[{"href":"https:\/\/lsacademy.com\/it\/wp-json\/wp\/v2\/media?parent=2407"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/lsacademy.com\/it\/wp-json\/wp\/v2\/product_brand?post=2407"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/lsacademy.com\/it\/wp-json\/wp\/v2\/product_cat?post=2407"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/lsacademy.com\/it\/wp-json\/wp\/v2\/product_tag?post=2407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>Jens-Otto Andreas – Project Lead Statistician<\/em> at UCB Biosciences GmbH
\nLisa Comarella – Director Biostatistics<\/em> at CROS NT
\nGiacomo Mordenti – Head of Biostatistics & Data Management Europe<\/em> at Daiichi Sankyo Europe GmbH
\nMarc Vandemeulebroecke – Global Group Head for Dermatology<\/em> at Novartis Biostatistics<\/p>\n
\n<\/strong>The conference is addressed to statisticians, pharmacometricians, physicians, regulators, academia and other experts interested in the field belonging to: Pharmaceutical, and Biotechnology companies, CROs, Universities\/Hospitals, Academic Research.<\/p>\n","protected":false},"excerpt":{"rendered":"